Members of the Duke Neurology Department contributed to 13 new peer-reviewed journal articles this May, advancing our understanding of how viruses that kill cancer cells may be used against brain tumors, the optimal treatments for various types of stroke, the origins of Parkinson’s disease, and more. Read the paragraphs below for summaries of our research from the past 31 days, as well as links to the complete articles themselves.
The newest NIH Alzheimer’s Disease Research Center (ADRC)—a collaboration established in Fall 2021 between Duke and the University of North Carolina (UNC)—is focused on identifying age-related changes across the lifespan that impact the development, progression, and experience of Alzheimer’s disease and related dementias. The center will also identify how factors that arise in early- and mid-life contribute to racial, ethnic, and geographic disparities in dementia.
This March, members of our Department contributed to studies that reveal potential new therapeutic targets for Alzheimer’s disease, help triage patients suffering from traumatic brain injury, address issues contributing to physician burnout, and more. In all, our faculty, staff, students, and trainees contributed to 15 studies published over the past 31 days. Read about them and find links to the original articles below.
Parkinson’s and Movement Disorders
Zhiyong Liu, PhD, learned about the devastating effects neurodegenerative diseases have on patients and their families firsthand during his senior year of college, when he worked in a clinical research lab. Now, as a postdoctoral associate within the lab of Andy West, PhD, he’s performing translational research to develop new treatments for one of those conditions, Alzheimer’s disease. In this week’s “Spotlight” interview, Liu talks about the focus of his work, his recent K99/R00 award, and enjoying running, fishing, and time with his family when he’s not at work.
This week’s “Spotlight” interview shines on Amy Obssi, our newest clinical research coordinator in the division of Memory Disorders. Obssi talks to us about her role in helping to conduct research into treatments for Alzheimer’s disease and other dementias both at Duke and in her previous role at Toronto Western Hospital.
The first month of 2022 saw the publication of 18 new peer-reviewed journal articles from members of the Duke Neurology Department. Highlights include a new article in Lancet Neurology discussing the epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders, case reports describing the progression and treatment options for rare neurological conditions, and a summary of how the first year of the COVID-19 pandemic affects neurology residency programs in the United States.
Research authored by members of the Duke Neurology Department published during the final month of 2021 advanced our knowledge of stroke, epilepsy, dystonia, and other conditions.
Members of the Duke Neurology Department contributed to 14 new peer-reviewed journal articles written this November. Highlights include an analysis of fragmentation within the delivery of neurological health care, an examination of racial disparities in the use of telehealth, and a discussion of the best ways to use social medicine to share news on epilepsy and clinical neurophysiology. Read the paragraphs below for short summaries of each of these 14 articles, as well as links to the original entries themselves.
New research from the Duke Neurology Department provided insights into our ability to improve patient care and better understand neurological conditions. The 11 studies featuring our faculty, staff, and trainees published this September include the discovery of an HIV medication’s surprising potential to treat dystonia, an analysis of brain tumor patients admitted to intensive care, and a personal story of one faculty member’s grandfather, who lived through the ups and downs of a century of health care in the United States.
Duke University and the University of North Carolina at Chapel Hill have been awarded funds from the National Institutes of Health to establish a prestigious Alzheimer’s Disease Research Center (ADRC), part of a federally-funded national network of similar centers.